<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36927380</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1546-0096</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>16</Day></PubDate></JournalIssue><Title>Pediatric rheumatology online journal</Title><ISOAbbreviation>Pediatr Rheumatol Online J</ISOAbbreviation></Journal><ArticleTitle>Clinical phenotypes and prognosis of cytomegalovirus infection in the pediatric systemic lupus erythematosus: a longitudinal analysis.</ArticleTitle><Pagination><StartPage>25</StartPage><MedlinePgn>25</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">25</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12969-023-00807-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cytomegalovirus (CMV) plays an important role in the pathogenesis of systemic lupus erythematosus (SLE). However, it is not clear whether the anti-CMV treatment has an impact on the prognosis of SLE patients with CMV infection. We aimed to analyze the clinical characteristics and prognosis of CMV infection in pediatric SLE (pSLE) and to evaluate the effect of anti-CMV treatment on pSLE outcome.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective study including 146 pSLE from 2012 to 2021 was conducted. CMV-positive and CMV-negative groups were compared by univariate analysis and stepwise logistic multiple regression to analyze the clinical characteristics of CMV infection in pSLE. Generalized estimating equations (GEE) were used to model the longitudinal dynamics of pSLE disease activity with or without CMV infection and anti-CMV treatment.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The CMV infection rate was 74.7% (109/146) in this pSLE cohort. CMV-positive pSLE patients were more likely to present positive anti-dsDNA antibody, hypocomplementemia, high SLEDAI-2K score and musculoskeletal involvement (P &lt; 0.05). Survival analysis showed that CMV-positive pSLE patients were more prone to disease flare and poorer outcomes. GEE modeling indicated that CMV phosphoprotein 65 (pp65) titers were positively correlated with SLEDAI-2K, and anti-CMV treatment could better reduce pSLE activity than non-treatment (P &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">CMV infection is highly prevalent among pSLE patients. Positive anti-dsDNA antibody, hypocomplementemia, high SLEDAI-2K score and musculoskeletal involvement were significant clinical clues indicating CMV infections in pSLE. CMV infection is correlated with higher disease activity and poorer outcome. Anti-CMV treatment can reduce disease activity and flares.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Tianyu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Zhongxun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Sihao</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yuelun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Changyan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jian</LastName><ForeName>Shan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gou</LastName><ForeName>Lijuan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ji</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Mingsheng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Hongmei</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-9801-2517</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China. songhm1021@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2021YFC2702005</GrantID><Agency>National Key R&amp;D Program of China</Agency><Country/></Grant><Grant><GrantID>2022-PUMCH-B-079</GrantID><Agency>National High Level Hospital Clinical Research Funding</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pediatr Rheumatol Online J</MedlineTA><NlmUniqueID>101248897</NlmUniqueID><ISSNLinking>1546-0096</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003586" MajorTopicYN="Y">Cytomegalovirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anti-CMV treatment</Keyword><Keyword MajorTopicYN="N">Clinical phenotypes</Keyword><Keyword MajorTopicYN="N">Cytomegalovirus infection</Keyword><Keyword MajorTopicYN="N">Phosphoprotein 65</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>17</Day><Hour>8</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36927380</ArticleId><ArticleId IdType="pmc">PMC10022138</ArticleId><ArticleId IdType="doi">10.1186/s12969-023-00807-w</ArticleId><ArticleId IdType="pii">10.1186/s12969-023-00807-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pineles D, Valente A, Warren B, Peterson MG, Lehman TJ, Moorthy LN. Worldwide incidence and prevalence of pediatric onset systemic lupus erythematosus. Lupus. 2011;20(11):1187&#x2013;92. doi: 10.1177/0961203311412096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203311412096</ArticleId><ArticleId IdType="pubmed">21768176</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EMD, Lythgoe H, Midgley A, Beresford MW, Hedrich CM. Juvenile-onset systemic lupus erythematosus: Update on clinical presentation, pathophysiology and treatment options. Clin Immunol. 2019;209:108274. doi: 10.1016/j.clim.2019.108274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2019.108274</ArticleId><ArticleId IdType="pubmed">31678365</ArticleId></ArticleIdList></Reference><Reference><Citation>Hrycek A, Kusmierz D, Mazurek U, Wilczok T. Human cytomegalovirus in patients with systemic lupus erythematosus. Autoimmunity. 2005;38(7):487&#x2013;91. doi: 10.1080/08916930500285667.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916930500285667</ArticleId><ArticleId IdType="pubmed">16373253</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Mercado AE, Vila-Perez S. Cytomegalovirus as a trigger for systemic lupus erythematosus. J Clin Rheumatol. 2010;16(7):335&#x2013;7. doi: 10.1097/RHU.0b013e3181f4cf52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RHU.0b013e3181f4cf52</ArticleId><ArticleId IdType="pubmed">20859222</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozenblyum EV, Allen UD, Silverman ED, Levy DM. Cytomegalovirus infection in childhood-onset systemic lupus erythematosus. Int J Clin Rheumtol. 2013;8(1):137&#x2013;46. doi: 10.2217/ijr.12.82.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/ijr.12.82</ArticleId><ArticleId IdType="pmc">PMC3920748</ArticleId><ArticleId IdType="pubmed">24527062</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725. doi: 10.1002/art.1780400928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71(9):1400&#x2013;12. doi: 10.1002/art.40930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40930</ArticleId><ArticleId IdType="pmc">PMC6827566</ArticleId><ArticleId IdType="pubmed">31385462</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">11838846</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozenblyum EV, Levy DM, Allen U, Harvey E, Hebert D, Silverman ED. Cytomegalovirus in pediatric systemic lupus erythematosus: prevalence and clinical manifestations. Lupus. 2015;24(7):730&#x2013;5. doi: 10.1177/0961203314565443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314565443</ArticleId><ArticleId IdType="pubmed">25568145</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoda Y, Hanaoka R, Ide H, Isozaki T, Matsunawa M, Yajima N, et al. Clinical evaluation of patients with inflammatory connective tissue diseases complicated by cytomegalovirus antigenemia. Mod Rheumatol. 2006;16(3):137&#x2013;42. doi: 10.3109/s10165-006-0470-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/s10165-006-0470-x</ArticleId><ArticleId IdType="pubmed">16767551</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto D, Matsushima A, Nagao M, Takakura S, Ichiyama S. Risk factors associated with elevated blood cytomegalovirus pp65 antigen levels in patients with autoimmune diseases. Mod Rheumatol. 2013;23(2):345&#x2013;50. doi: 10.3109/s10165-012-0651-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/s10165-012-0651-8</ArticleId><ArticleId IdType="pubmed">22534885</ArticleId></ArticleIdList></Reference><Reference><Citation>Takizawa Y, Inokuma S, Tanaka Y, Saito K, Atsumi T, Hirakata M, et al. Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population. Rheumatology (Oxford). 2008;47(9):1373&#x2013;8. doi: 10.1093/rheumatology/ken231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ken231</ArticleId><ArticleId IdType="pubmed">18577548</ArticleId></ArticleIdList></Reference><Reference><Citation>Lino K, Trizzotti N, Carvalho FR, Cosendey RI, Souza CF, Klumb EM, et al. Pp65 antigenemia and cytomegalovirus diagnosis in patients with lupus nephritis: report of a series. J Bras Nefrol. 2018;40(1):44&#x2013;52. doi: 10.1590/2175-8239-jbn-3838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/2175-8239-jbn-3838</ArticleId><ArticleId IdType="pmc">PMC6533970</ArticleId><ArticleId IdType="pubmed">29796586</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Dou Y, Zhong Z, Su J, Xu D, Tang F, et al. Clinical characteristics and therapy exploration of active human cytomegalovirus infection in 105 lupus patients. Lupus. 2014;23(9):889&#x2013;97. doi: 10.1177/0961203314532560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314532560</ArticleId><ArticleId IdType="pubmed">24836584</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Danziger-Isakov L, et al. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2013;96(4):333&#x2013;60. doi: 10.1097/TP.0b013e31829df29d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0b013e31829df29d</ArticleId><ArticleId IdType="pubmed">23896556</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldanti F, Lilleri D, Gerna G. Monitoring human cytomegalovirus infection in transplant recipients. J Clin Virol. 2008;41(3):237&#x2013;41. doi: 10.1016/j.jcv.2007.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2007.12.001</ArticleId><ArticleId IdType="pubmed">18203657</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui J, Yan W, Xie H, Xu S, Wang Q, Zhang W, et al. Cytomegalovirus antigenemia in patients with autoimmune and non-autoimmune diseases in Beijing: A 10-year single hospital experience. PLoS One. 2019;14(8):e0221793. doi: 10.1371/journal.pone.0221793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0221793</ArticleId><ArticleId IdType="pmc">PMC6713388</ArticleId><ArticleId IdType="pubmed">31461496</ArticleId></ArticleIdList></Reference><Reference><Citation>Soderberg-Naucler C. Autoimmunity induced by human cytomegalovirus in patients with systemic lupus erythematosus. Arthritis Res Ther. 2012;14(1):101. doi: 10.1186/ar3525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3525</ArticleId><ArticleId IdType="pmc">PMC3392786</ArticleId><ArticleId IdType="pubmed">22277352</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneshita S, Kida T, Yokota I, Nagahara H, Seno T, Wada M, et al. Risk factors for cytomegalovirus disease with cytomegalovirus re-activation in patients with rheumatic disease. Mod Rheumatol. 2020;30(1):109&#x2013;15. doi: 10.1080/14397595.2018.1551264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14397595.2018.1551264</ArticleId><ArticleId IdType="pubmed">30472908</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia J, Shi H, Liu M, Liu T, Gu J, Wan L, et al. Cytomegalovirus Infection May Trigger Adult-Onset Still&#x2019;s Disease Onset or Relapses. Front Immunol. 2019;10:898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6491741</ArticleId><ArticleId IdType="pubmed">31068953</ArticleId></ArticleIdList></Reference><Reference><Citation>Davignon JL, Combe B, Cantagrel A. Cytomegalovirus infection: friend or foe in rheumatoid arthritis? Arthritis Res Ther. 2021;23(1):16. doi: 10.1186/s13075-020-02398-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-020-02398-3</ArticleId><ArticleId IdType="pmc">PMC7792325</ArticleId><ArticleId IdType="pubmed">33413603</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai WP, Chen MH, Lee MH, Yu KH, Wu MW, Liou LB. Cytomegalovirus infection causes morbidity and mortality in patients with autoimmune diseases, particularly systemic lupus: in a Chinese population in Taiwan. Rheumatol Int. 2012;32(9):2901&#x2013;8. doi: 10.1007/s00296-011-2131-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-011-2131-4</ArticleId><ArticleId IdType="pubmed">21898057</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin L, Qiu Z, Hsieh E, Geng T, Zhao J, Zeng X, et al. Association between lymphocyte subsets and cytomegalovirus infection status among patients with systemic lupus erythematosus: A pilot study. Medicine (Baltimore). 2019;98(39):e16997. doi: 10.1097/MD.0000000000016997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000016997</ArticleId><ArticleId IdType="pmc">PMC6775378</ArticleId><ArticleId IdType="pubmed">31574798</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CS, Chyuan IT, Chiu YL, Chen WL, Shen CY, Hsu PN. Preserved specific anti-viral T-cell response but associated with decreased lupus activity in SLE patients with cytomegalovirus infection. Rheumatology (Oxford). 2020;59(11):3340&#x2013;9. doi: 10.1093/rheumatology/keaa143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa143</ArticleId><ArticleId IdType="pubmed">32306043</ArticleId></ArticleIdList></Reference><Reference><Citation>Su BY, Su CY, Yu SF, Chen CJ. Incidental discovery of high systemic lupus erythematosus disease activity associated with cytomegalovirus viral activity. Med Microbiol Immunol. 2007;196(3):165&#x2013;70. doi: 10.1007/s00430-007-0040-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-007-0040-7</ArticleId><ArticleId IdType="pubmed">17318574</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee PP, Lee TL, Ho MH, Wong WH, Lau YL. Recurrent major infections in juvenile-onset systemic lupus erythematosus&#x2013;a close link with long-term disease damage. Rheumatology (Oxford). 2007;46(8):1290&#x2013;6. doi: 10.1093/rheumatology/kem102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kem102</ArticleId><ArticleId IdType="pubmed">17522097</ArticleId></ArticleIdList></Reference><Reference><Citation>HoHsieh A, Wang CM, Wu YJ, Chen A, Chang MI, Chen JY. B cell epitope of human cytomegalovirus phosphoprotein 65 (HCMV pp65) induced anti-dsDNA antibody in BALB/c mice. Arthritis Res Ther. 2017;19(1):65. doi: 10.1186/s13075-017-1268-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-017-1268-2</ArticleId><ArticleId IdType="pmc">PMC5359867</ArticleId><ArticleId IdType="pubmed">28320458</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh AH, Kuo CF, Chou IJ, Tseng WY, Chen YF, Yu KH, et al. Human cytomegalovirus pp65 peptide-induced autoantibodies cross-reacts with TAF9 protein and induces lupus-like autoimmunity in BALB/c mice. Sci Rep. 2020;10(1):9662. doi: 10.1038/s41598-020-66804-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-66804-1</ArticleId><ArticleId IdType="pmc">PMC7295797</ArticleId><ArticleId IdType="pubmed">32541894</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>